Bio Solution Co.,Ltd. (KOSDAQ:086820)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,100.00
+80.00 (1.14%)
At close: Jun 11, 2026
Market Cap183.21B -31.6%
Revenue (ttm)15.82B +22.8%
Net Income654.91M
EPS27.01
Shares Out 25.80M
PE Ratio262.86
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume151,625
Open7,100.00
Previous Close7,020.00
Day's Range6,750.00 - 7,680.00
52-Week Range6,310.00 - 13,450.00
Beta-0.13
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About Bio Solution

Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds; and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds. It also provides reconstructed human mic... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 203
Stock Exchange KOSDAQ
Ticker Symbol 086820
Full Company Profile

Financial Performance

Financial Statements